Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
Solriamfetol May Curb OSA-Associated Excessive Daytime SleepinessSolriamfetol, an investigational norepinephrine-dopamine reuptake inhibitor, improved excessive daytime sleepiness associated with obstructive sleep apnea (OSA) in a phase 3 trial reported last month in Chest.
Reuters Health Information, December 2018
Risk-Score Insights on How DOACs Vary in Upper GI Bleed Risk Adding a proton-pump inhibitor to oral anticoagulation can defend against gastrointestinal bleeding, but with varying success, depending on which oral anticoagulant, especially in high-risk patients.
Medscape Medical News, December 2018
Botulinum Toxin for Post-op AF: Mixed Results Yield InsightsTwo randomized studies, two different results: considered together, they may say a lot about which patients may benefit most from intraoperative epicardial fat-pad botulinum toxin type A injections.
Medscape Medical News, December 2018
AHA 2018Closing Dialysis Fistula After Transplant Halts Cardiac RemodelingArteriovenous fistula ligation in stable renal transplant recipients led to reduced LV mass and cardiac chamber size vs controls, with no harmful effects on graft function, in an early study.
How to Know When It's Autoimmune EpilepsyA conversation between Drs Andrew Wilner and Batool Kirmani on the red flags your patient may have this difficult-to-diagnosis condition.
Medscape Neurology, December 6, 2018
The New Seizure TerminologyNo more 'grand mal' or even 'partial complex seizures.' Find out which terms are outdated and which are newer and more accurate.
Treating the Individual, Not the 'Average' Patient Using SPRINT trial data, researchers calculated a score to allow clinicians to measure how close their patient matches the study participants. John Mandrola, MD, sees a means to individualize therapy.
